Scott Leftwich insider trades
Open-market stock purchases and sales by Scott Leftwich, Director at Calidi Biotherapeutics, Inc, from SEC Form 4 filings since Dec 21, 2023.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -68%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 17, 2026 | CLDI Calidi Biotherapeutics, Inc | Bought (not open market) | — |
Companies traded
- CLDI Calidi Biotherapeutics, Inc: 1 buy, last Aug 17, 2026